Coronary/Structural Heart

Peijia Medical Brings China into the “Recoverable Era” with its TAVR Products

– Peijia Medical takes China into the “Recoverable Era” with its TAVR products featuring a second-generation transcatheter aortic valve replacement system approved for commercialization SUZHOU, China , June 28, 2021 / PRNewswire / – The TaurusElite ® Transcatheter Aortic Valve Replacement System (hereinafter referred to as “TaurusElite ® “) and which has been developed by Peijia Medical (9996. HK) It […]

Publications Validate Clinical Safety and Efficacy of Shockwave Intravascular Lithotripsy

Simultaneous Publication of Three Studies in the Journal of the American College of Cardiology: Cardiovascular Interventions SANTA CLARA, Calif., June 28, 2021 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, announced today that the safety, […]

Idorsia initiates the Phase 3 registration study with selatogrel for the treatment of acute myocardial infarction

Ad hoc announcement pursuant to Art. 53 LR Idorsia to host an investor webcast to discuss the Phase 3 study today at 14:30hrs CEST Allschwil, Switzerland – June 28, 2021 Idorsia Ltd (SIX: IDIA) today announced the initiation of the Phase 3 registration study “SOS-AMI” to evaluate the efficacy and […]

Empagliflozin reduced the risk of cardiovascular events and hospitalization for heart failure compared to DPP-4 inhibitors in people with type 2 diabetes

– Interim analysis of the EMPRISE real-world evidence study showed that empagliflozin was associated with a reduced risk in all-cause mortality, hospitalization for heart failure and acute kidney injury requiring dialysis, compared to DPP-4 inhibitors – This analysis, which includes European data pooled with data from Israel and East Asia, was presented […]

Cardiac Atrophy Findings May Set Course for Preventing Harm from Long Space Flights

Team led by scientists at Cincinnati Children’s discover molecular process behind dangerous loss of heart muscle CINCINNATI, June 24, 2021 /PRNewswire/ — In many situations, heart muscle cells do not respond to external stresses in the same ways that skeletal muscle cells do. But under some conditions, heart and skeletal muscles can both […]

OMRON Healthcare and Kyoto University Collaborative Research Program “Healthcare Medical AI” to prevent the events of cardiovascular diseases with AI and home measurement data

KYOTO, Japan, June 24, 2021 /PRNewswire/ — OMRON Healthcare Co., Ltd. (Head Office: Muko-city, Kyoto, Japan, President & CEO: Isao Ogino) and Kyoto University (Sakyo-ku, Kyoto-city Kyoto, Japan, President: Nagahiro Minato) today announced a new Collaborative Research Program called “Healthcare Medical AI” (Principal Researcher: Yasushi Okuno, Ph.D., Prof., Department of Biomedical Data Intelligence, Graduate School of Medicine, Kyoto University) to use […]

PREFECT Trial Outcomes Demonstrate MyoStrain® Ability to Detect & Predict Early Cardiotoxicity in Cancer Patients Undergoing Chemotherapy

MORRISVILLE, N.C., June 23, 2021 /PRNewswire/ — A new pivotal article validated Myocardial Solutions technology MyoStrain® (fSENC) for the early detection and prediction of cardiotoxicity (heart damage). The article was published in Circulation: Cardiovascular Imaging and highlights MyoStrain as an accurate and sensitive management tool that may help clinicians protect cancer patient heart health during […]

CentraCare First in World to Use 4D Hologram Technology to Successfully Complete Structural Heart Procedure

EchoPixel’s pre-planning and intra-operative technologies reduced complex heart procedure time while improving quality of outcomes ST. CLOUD, Minn., June 23, 2021 (GLOBE NEWSWIRE) — CentraCare, one of the largest health systems in Minnesota, has successfully completed the first structural heart procedure in the world using 4D hologram technology, which was developed […]

BioCardia Announces Fourth Positive DSMB Review and Recommendation to Continue Phase III Pivotal CardiAMP Cell Therapy Heart Failure Study as Designed

SAN CARLOS, Calif., June 23, 2021 (GLOBE NEWSWIRE) — BioCardia®, Inc. [Nasdaq: BCDA], a company focused on developing cellular and cell derived therapeutics for the treatment of cardiovascular and pulmonary disease, today announces that the independent Data Safety Monitoring Board (DSMB) has completed its prespecified data review for the Phase III pivotal CardiAMP™ […]

Fist Assist Devices, LLC Announces 510(k) Clearance for Focal Arm Massage and Increased Vein Circulation

LOS ALTOS HILLS, Calif.–(BUSINESS WIRE)–Fist Assist Devices, LLC, has received FDA 510(k) clearance for use of the Fist Assist FA-1 device in the United States as an arm massage and increased vein circulation device and has commenced marketing the Fist Assist FA-1 device for that indication for use. “We are […]